SLS BIO Co., Ltd (KOSDAQ:246250)
South Korea · Delayed Price · Currency is KRW 1,969.00
+85.00 (4.51%)
At close: Jun 9, 2025
SLS BIO Market Cap
SLS BIO has a market cap or net worth of 26.89 billion as of April 2, 2026. Its market cap has decreased by -16.57% in one year.
Market Cap
26.89B
Enterprise Value
20.82B
Revenue
3.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,969.00
Market Cap Chart
Since April 5, 2017, SLS BIO's market cap has decreased from 29.35B to 26.89B, a decrease of -8.39%. That is a compound annual growth rate of -1.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2025 | 26.89B | 2.29% |
| Dec 30, 2024 | 26.29B | -25.39% |
| Dec 28, 2023 | 35.23B | 3.72% |
| Dec 29, 2022 | 33.97B | -44.41% |
| Dec 30, 2021 | 61.11B | -20.80% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 640.18B |
| DreamCIS | 122.89B |
| HLB bioStep | 103.81B |
| P&K Skin Research Center | 59.79B |
| C&R Research | 46.09B |
| WOOJUNG BIO | 45.52B |
| DT&CRO CO. | 41.61B |
| BioInfra | 19.31B |